Related Experiment Video
Updated: Jul 13, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Key issues in multidrug-resistant tuberculosis.
Biswajit Chakrabarti1, Peter D O Davies
1Clinical Sciences Centre, University Hospital, Aintree, Liverpool, UK. biz@doctors.org.uk
Future Microbiology
|July 31, 2007
Summary
Multidrug-resistant tuberculosis (MDR-TB) is a growing global health threat. Rapid diagnosis and careful treatment are crucial for managing MDR-TB, with research needed for better therapies.
Area of Science:
- * Infectious Diseases
- * Microbiology
- * Public Health
Background:
- * Tuberculosis (TB) causes millions of deaths and new cases annually.
- * Multidrug-resistant tuberculosis (MDR-TB) presents a significant global challenge.
- * MDR-TB requires less effective, more toxic second-line treatments, prolonging infectious periods.
Purpose of the Study:
- * To highlight the challenges in managing multidrug-resistant tuberculosis.
- * To discuss factors contributing to MDR-TB emergence.
- * To review diagnostic and treatment strategies for MDR-TB.
Main Methods:
- * Review of existing literature on tuberculosis and MDR-TB.
- * Discussion of diagnostic advancements, including DNA amplification techniques like polymerase chain reaction (PCR).
- * Analysis of current treatment protocols and potential future therapeutic avenues.
Main Results:
- * MDR-TB necessitates prolonged treatment with multiple drugs, including injectable agents.
- * Previous inadequate TB treatment and physician prescription errors are key factors in MDR-TB development.
- * Rapid diagnosis of MDR-TB is achievable with molecular techniques.
Conclusions:
- * Effective management of MDR-TB requires meticulous infection control and isolation procedures.
- * Further research into novel antituberculous medications and immunotherapy is essential.
- * Surgery may be considered for select MDR-TB cases.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...